- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04362306
Radiation Oncology Patient Medical Physics Intervention Study
April 10, 2024 updated by: The University of Texas Health Science Center at San Antonio
This investigation is designed to be a two-arm, non-randomized prospective phase 2 study evaluating the impact of medical physicist patient intervention on the anxiety level and patient satisfaction of patients undergoing a course of radiation therapy.
The goal is to demonstrate that these interventions will have a significantly positive impact on the overall well-being of the oncology patients.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Anna Laura Licon, BS
- Phone Number: 210-450-5545
- Email: liconal@livemail.uthscsa.edu
Study Contact Backup
- Name: Carol Jenkins, RN
- Phone Number: Jenkins
- Email: jenkinsca@uthscsa.edu
Study Locations
-
-
Texas
-
San Antonio, Texas, United States, 78229
- Recruiting
- Mays Cancer Center, UT Health San Antonio
-
Contact:
- Carol Jenkins, RN, MSN
- Phone Number: 210-450-5924
- Email: jenkinsca@uthscsa.edu
-
Principal Investigator:
- Timothy Wagner, MD, MBA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age >/= 18 years
- Patients receiving treatment in the outpatient setting.
- Patients with an Eastern Cooperative Oncology Group Performance Status (ECOG PS) 0, 1, or 2.
Exclusion Criteria:
- Patients receiving a single fraction of treatment.
- History of Prior Radiation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Planned Intervention
Patients will be scheduled for CT (computed tomography ) simulation for radiation treatment planning.
Prior to simulation, patients will be asked to complete anxiety and patient satisfaction questionnaires.
Following completion of the questionnaires, each patient will receive the first intervention with a member of the medical physics team to review the process of simulation, treatment planning, and subsequent treatment.
This meeting will last approximately 15 minutes and at this time, the team member will explain that they are the primary resource for all the technical aspects related to the patient's treatment.
Additionally, they will identify and address any concerns that patients or their caregivers have with radiation treatment and the patient will be shown the simulation infographic.
The patient will then be asked to complete a second set of anxiety and patient satisfaction questionnaires and will then undergo the planned simulation.
|
Intervention with a member of the medical physics team to review the process of simulation, treatment planning, and subsequent treatment.
This meeting will last approximately 15 minutes and at this time, the team member will explain that they are the primary resource for all the technical aspects related to the patient's treatment.
Additionally, they will identify and address any concerns that patients or their caregivers have with radiation treatment and the patient will be shown the simulation infographic.
|
Active Comparator: No Planned Intervention
After patients are enrolled into this study, they will be scheduled for CT simulation for radiation treatment planning.
Prior to simulation, patients will receive anxiety and patient satisfaction questionnaires to complete
|
Anxiety and patient satisfaction questionnaires will be completed prior to CT simulation.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety Inventory
Time Frame: Baseline to last treatment (up to 9 weeks)
|
The change in score from 6 questions in the validated short-form of the Spielberger State-Trait Anxiety Inventory (STAI).10
The mean medical physics intervention cohort anxiety score will be calculated at each of the 4 time points and compare to the same time points for the control cohort.
|
Baseline to last treatment (up to 9 weeks)
|
Patient Satisfaction
Time Frame: Baseline to last treatment (up to 9 weeks)
|
Change in mean Function Assessment of Chronic Illness Therapy Treatment Satisfaction Patient Satisfaction score for the control and intervention groups will be compared.
|
Baseline to last treatment (up to 9 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Medical competency/health literacy of Spanish speaking patients
Time Frame: Prior to CT simulation
|
Analyze medical competency/health literacy through a one-time, 3-question medical competency questionnaire.
|
Prior to CT simulation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Timothy Wagner, MD, MBA, University of Texas
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 3, 2020
Primary Completion (Estimated)
August 1, 2024
Study Completion (Estimated)
August 1, 2025
Study Registration Dates
First Submitted
April 14, 2020
First Submitted That Met QC Criteria
April 23, 2020
First Posted (Actual)
April 24, 2020
Study Record Updates
Last Update Posted (Actual)
April 12, 2024
Last Update Submitted That Met QC Criteria
April 10, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- CTMS# 19-0182
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiRecruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
Dr. Nazanin AlaviActive, not recruitingGeneralized Anxiety Disorder | AnxietyCanada
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
-
Loma Linda UniversityCompletedParental/Caregiver Anxiety | Child's AnxietyUnited States
Clinical Trials on Planned Intervention
-
IHF GmbH - Institut für HerzinfarktforschungAbbottRecruiting
-
Korean Cardiac Arrest Research ConsortiumRecruiting
-
University of TartuNorth Estonian Medical CenterCompleted
-
University Hospital HeidelbergCompleted
-
Fundacion GESICAEscuela de Psicología Social Pichon Riviere; Corriente Salvador MazaActive, not recruitingCardiovascular Diseases | Cardiovascular Risk FactorArgentina
-
University of ZurichCompletedTinnitus, SubjectiveGermany, Switzerland
-
University of Texas Southwestern Medical CenterNational Institutes of Health (NIH)CompletedObesity | Type 2 DiabetesUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
University Hospital HeidelbergRecruitingCardiomyopathies | Skeletal Muscle DisorderGermany
-
Federal State Budgetary Institution, V. A. Almazov...RecruitingSleep Disorder | Stroke, IschemicRussian Federation